Suchergebnisse - "Brown, Jennifer R"

PubPharm (132)

1

A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia

enthalten in: Investigational new drugs | 2021

von Danilov, A. | Spurgeon, S. | Siddiqi, T. | +4

2

Current Status of Bruton’s Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies

enthalten in: Drugs & aging | 2017

von Aw, A. | Brown, J.

3

Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells

enthalten in: Nature | 2017

von Compagno, M. | Wang, Q. | Pighi, C. | +17

4

Ventricular arrhythmias and sudden death in patients taking ibrutinib

enthalten in: Blood | 2017

von Lampson, B. | Yu, L. | Glynn, R. | +9

5

Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation

enthalten in: Clinical cancer research | 2017

von Yu, L. | Kim, H. | Kasar, S. | +13

6

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The lancet / Oncology | 2017

von Zelenetz, A. | Barrientos, J. | Brown, J. | +20

7

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2017

von Herrera, A. | Mei, M. | Low, L. | +37

8

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The lancet / Oncology | 2017

von Zelenetz, A. | Barrientos, J. | Brown, J. | +20

9

A phase I dose‐ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities

enthalten in: British journal of haematology | 2017

von Danilov, A. | Lewis, L. | Lansigan, F. | +6

10

Using Targeted Inhibitors in the Management of Chronic Lymphocytic Leukemia : Are We There Yet?

enthalten in: Oncology (Williston Park, N.Y.) | 2016

von Brown, J.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]